Latest filing published 23 Jun 2026 for Guardant Health, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Myrtle S. Potter has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Guardant Health, Inc., Myovant Sciences Ltd. and Ginkgo Bioworks Holdings, Inc. The record holds 46 filings, for trades running from 15 October 2022 to 22 June 2026.
Sales make up the whole of the open-market record (5 sales, €5,005). The totals do not cover 1 filing with an undisclosed amount. The rest of the record consists of 4 share grants and 36 option exercises. Since January 2026: no purchases and 1 sale on the market.
The record was last updated on 23 June 2026 with an open-market sale in Guardant Health, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations